Huasun(SZ:000790) Zheng Quan Zhi Xing·2025-08-01 16:35Audit Opinion - The audit report states that the financial statements of Tibet Kangyu Pharmaceutical Co., Ltd. fairly reflect its financial position as of December 31, 2024, and April 30, 2025, in accordance with accounting standards [2][3]. Company Overview - Tibet Kangyu Pharmaceutical Co., Ltd. was established on March 18, 2015, with a registered capital of RMB 10 million, fully paid [5]. - The company operates in the wholesale industry, primarily engaged in the sale of pharmaceuticals and medical devices, along with various other products [5]. Financial Reporting Basis - The financial statements are prepared based on the going concern assumption, indicating that the company has the ability to continue its operations for at least the next 12 months [6]. - The financial statements comply with the requirements of the accounting standards, providing a true and complete reflection of the company's financial status, operating results, and cash flows [6]. Accounting Policies and Estimates - The company uses the perpetual inventory system for its inventory management, valuing inventory at actual cost upon acquisition [22]. - The company recognizes financial assets and liabilities based on their classification, including those measured at amortized cost and those measured at fair value [10][12]. Financial Instruments - Financial assets are classified based on the business model for managing them and their contractual cash flow characteristics [6][10]. - The company applies the expected credit loss model for impairment accounting, assessing credit risk based on historical experience and current conditions [16][19]. Long-term Investments - Long-term equity investments are accounted for using the cost method for subsidiaries and the equity method for joint ventures and associates [26][27]. - The company evaluates its long-term investments based on the fair value of the underlying assets and adjusts the carrying amount accordingly [24][28].